Cyprus Mail

Vodafone helps FTSE post second day of gains

BRITAIN’S top equity index rose for a second straight day on Thursday, led by strong gains from heavyweight telecoms group which helped the market recover its poise after a recent five-day losing streak.

The blue-chip FTSE 100 index, which had fallen for five straight days during the past two weeks, closed up 100.39 points, or 1.6 per cent, at 6,558.28 points.

Investors had been unnerved by signs of slower Chinese growth and the withdrawal of U.S. monetary stimulus, concerns that spread from emerging markets to the world’s big stock markets.

A 3.7 per cent rise in Vodafone, after the mobile operator expressed confidence that its revenues would improve, contributed the most points to the FTSE 100 index on Thursday.

Toby Campbell-Gray, head of trading at Tavira Securities, said Vodafone kept attracting investors because of its solid dividend yield and because of speculation about a takeover, even though AT&T ruled out a bid for Vodafone last month.

A bounce back in emerging market currencies proved supportive to the likes of consumer goods maker Unilever and brewer SABMiller, which have big EM exposure. For a list of European blue-chips with the most exposure to emerging markets:

And, with much of the market focus on Friday’s U.S. non-farm payrolls report, investors took heart from a better-than-expected report on U.S. weekly initial jobless claims.

“This bounce could be due to speculators abandoning their bearish positions ahead of the NFP. All eyes will be on the 200-day moving average again (currently at 6,563). If the index closes above it… then we could well see some healthy gains next week,” Gain Capital technical analyst Fawad Razaqzada said.

One cause for concern is that the earnings picture overall remains mixed, underscored by a warning from AstraZeneca that it has another difficult year ahead in the face of generic competition for its popular heartburn and ulcer drug Nexium.

Its shares dropped 1.6 per cent, the biggest drag on the UK benchmark. The loss trimmed the drugmaker’s advance this year to around 7 per cent, as analysts flagged a likely downgrade to the consensus forecast for its 2014 earnings.

Cautious results statements are sounding alarm bells for investors who had been betting on a recovery in European earnings as the main driver for an equity market rally in 2014.

With the market already trading at lofty valuations after a bumper 2013, bolstered by central bank stimulus, analysts say that valuations have little scope to make further gains, which means earnings must increase before prices can.

A lacklustre start to the earnings season has contributed to a drop of around 3 per cent on the FTSE 100 in 2014.

Of the 26 per cent of European companies to have reported so far, 39 per cent have missed profits expectations and 44 per cent have missed expectations on revenue, Thomson Reuters Starmine data shows.

But investors with a view over all of 2014 remain bullish, expecting a pick-up in earnings in the next quarterly reporting season.

“The fact that clients are still happy to position themselves long and not to take aggressive shorts on the index against their long equity positions probably suggests that they’re confident that there will be a turnaround,” said Matt Basi, head of sales trading at CMC Markets.

Related Posts

Gloom for tourism sector in the north despite uptick

Kyriacos Nicolaou

Economic sentiment deteriorates in June

Source: Cyprus News Agency

Ether holds its breath for the lean, mean ‘merge’

Reuters News Service

A ‘default’ when flush with cash: Five signs Russia ain’t sinking yet

Reuters News Service

Egypt can no longer depend on hot money for budget: finance minister

Reuters News Service

China extends anti-dumping tariffs on EU, UK steel fasteners imports

Reuters News Service

1 comment

Comments are closed.